SAM
Senzar Asset Management Portfolio holdings
AUM
$34.7M
This Quarter Return
+4.44%
1 Year Return
+0.55%
3 Year Return
-0.75%
5 Year Return
–
10 Year Return
–
AUM
$383M
AUM Growth
+$383M
(-5.8%)
Cap. Flow
-$48M
Cap. Flow
% of AUM
-12.55%
Top 10 Holdings %
Top 10 Hldgs %
73.29%
Holding
40
New
16
Increased
1
Reduced
10
Closed
12
Top Buys
| 1 |
Sanofi
SNY
|
$39.7M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$34.6M |
| 3 |
AGN.PRA
Allergan plc.
AGN.PRA
|
$32.2M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$28.3M |
| 5 |
Encompass Health
EHC
|
$21.3M |
Top Sells
| 1 |
Viatris
VTRS
|
$35.2M |
| 2 |
Neurocrine Biosciences
NBIX
|
$34.5M |
| 3 |
Eli Lilly
LLY
|
$34.2M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
$33.7M |
| 5 |
Gilead Sciences
GILD
|
$26.5M |
Sector Composition
| 1 | Healthcare | 86.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Halozyme
HALO
$8.56B
| $66.5M | 16.24% |
3,830,190
-257,074
| -6% | -$4.47M |
|
|
2
Sanofi
SNY
$121B
| $39.7M | 9.69% |
+797,486
| New | +$39.7M |
|
|
3
Regeneron Pharmaceuticals
REGN
$61.5B
| $34.6M | 8.44% |
+77,300
| New | +$34.6M |
|
|
AGN.PRA
4
DELISTED
Allergan plc.
AGN.PRA
| $32.2M | 7.85% |
+43,600
| New | +$32.2M |
|
|
TSRO
5
DELISTED
TESARO, Inc.
TSRO
| $28.3M | 6.92% |
+219,500
| New | +$28.3M |
|
6
Elevance Health
ELV
$71.8B
| $24.1M | 5.87% |
126,700
-17,650
| -12% | -$3.35M |
|
|
7
Encompass Health
EHC
$12.3B
| $21.3M | 5.2% |
+459,600
| New | +$21.3M |
|
|
AGN
8
DELISTED
Allergan plc
AGN
| $12.3M | 3.01% |
+60,100
| New | +$12.3M |
|
|
AERI
9
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $11.2M | 2.74% |
231,200
-160,200
| -41% | -$7.79M |
|
10
TG Therapeutics
TGTX
$4.65B
| $10.2M | 2.5% |
863,500
-105,800
| -11% | -$1.25M |
|
11
Globus Medical
GMED
$8.27B
| $9.79M | 2.39% |
+329,400
| New | +$9.79M |
|
12
Medtronic
MDT
$119B
| $9.58M | 2.34% |
+123,200
| New | +$9.58M |
|
|
CLVS
13
DELISTED
Clovis Oncology, Inc.
CLVS
| $9.26M | 2.26% |
+112,400
| New | +$9.26M |
|
14
Ironwood Pharmaceuticals
IRWD
$214M
| $8M | 1.95% |
+507,000
| New | +$8M |
|
|
ALDR
15
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $7.85M | 1.92% |
641,170
+83,400
| +15% | +$1.02M |
|
16
Insmed
INSM
$28.8B
| $7.45M | 1.82% |
+238,700
| New | +$7.45M |
|
|
ESRX
17
DELISTED
Express Scripts Holding Company
ESRX
| $6.9M | 1.68% |
108,901
-532,400
| -83% | -$33.7M |
|
18
Universal Health Services
UHS
$11.6B
| $6.79M | 1.66% |
+61,200
| New | +$6.79M |
|
19
Pediatrix Medical
MD
$1.5B
| $6.6M | 1.61% |
+153,000
| New | +$6.6M |
|
20
Theravance Biopharma
TBPH
$699M
| $6.24M | 1.52% |
+182,100
| New | +$6.24M |
|
|
CNCE
21
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $4.95M | 1.21% |
335,445
-76,700
| -19% | -$1.13M |
|
|
CORI
22
DELISTED
Corium International, Inc.
CORI
| $4.93M | 1.2% |
445,166
-358,600
| -45% | -$3.97M |
|
|
ELGX
23
DELISTED
Endologix Inc
ELGX
| $4.02M | 0.98% |
+901,541
| New | +$4.02M |
|
24
Protagonist Therapeutics
PTGX
$3.67B
| $3.91M | 0.95% |
221,000
-52,500
| -19% | -$928K |
|
|
FOMX
25
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $2.57M | 0.63% |
463,297
-105,900
| -19% | -$588K |
|